Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms.
Ratings
4 / 5
3 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Steven Cutler$25.5B
Market Cap • 24/04/20241990
(há 34 anos)
1998
(26 years ago)
NASDAQ
Listagem
Dublin
41.150
N° de Empregados • 2023Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ICLRSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.